TITLE

Nebulisers for asthma

AUTHOR(S)
Ward, M. J.
PUB. DATE
April 1997
SOURCE
Thorax;Apr1997, pS45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66876974

 

Related Articles

  • Salbutamol.  // Reactions Weekly;9/17/2011, Issue 1369, p34 

    The article describes the case of a man who developed lactic acidosis during treatment with salbutamol nebulisers for asthma.

  • Home nebulisers in childhood asthma: survey of hospital supervised use. Bendely, Ilona M. // BMJ: British Medical Journal (International Edition);5/18/91, Vol. 302 Issue 6786, p1180 

    Examines the implications of home nebulisers for the management and outcome of asthma in children in Great Britain. Frequency of hospital admissions and side effects after using bronchodilators; Weight-related dosage of home nebulisers; Advisory on the management of severe asthma attacks.

  • Budesonide.  // Reactions Weekly;4/2/2011, Issue 1345, p10 

    The article describes the case of a 4-year-old boy who was given nebulised budesonide solution for cough and wheezing associated with asthma was found to have cataracts.

  • Best practice in the provision of nebuliser therapy. Kelly, Carol; Lynes, David // Nursing Standard;4/6/2011, Vol. 25 Issue 31, p50 

    Nebulisation is an important and common method of administering medication to patients with respiratory disease. Although the routine use of nebulisers is contentious, they are helpful when the patient is unable to use other devices, perhaps because of illness or poor dexterity, and are...

  • Review: Spacers and nebulizers for delivery of β2-agonists do not differ for clinical outcomes in acute asthma. Thien, Francis // Annals of Internal Medicine;2/18/2014, Vol. 160 Issue 4, pJC9 

    The article presents a research titled "Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma" by C. J. Cates and colleagues, that was published in the journal "Cochrane Database of Systematic Reviews" in 2013. Topics discussed include efficacy of nebulisers and...

  • Salbutamol.  // Reactions Weekly;9/29/2007, Issue 1171, p24 

    The article presents a case study of a 41-year-old man, who had a 40 pack/year smoking history and a 3-year history of asthma, experienced bronchoconstriction following inhalation of salbutamol for asthma exacerbation. After receiving methylprednisolone and formoterol, he felt breathless and...

  • Medical foot pump compressors have been available for many years as an option for human powered nebulisation. Masters, Nigel // Primary Care Respiratory Society UK;9/18/2014, p1 

    A letter to the editor is presented in response to the article "Treatment of Asthma Exacerbations With the Human-Powered Nebuliser: A Randomised Parallel-Group Clinical Trial" by C.J. Hallberg and colleagues in Volume 24, 2014 issue.

  • Oxygen as a driving gas for nebulisers: safe or dangerous? Gunawardena, K.A.; Patel, B.; Campbell, I.A.; MacDonald, J.B.; Smith, A.P. // British Medical Journal (Clinical Research Edition);1/28/1984, Vol. 288 Issue 6413, p272 

    Examines the effectiveness of oxygen as a driving gas for nebulisers. Types of patients with airways obstruction; Use of nebulized bronchodilators in the management of severe asthma; Details on the exacerbations of chronic obstructive airways disease.

  • Understanding statistics--"Is there a significant difference?" Walsh, Kieran // BMJ: British Medical Journal (International Edition);2/28/2004, Vol. 328 Issue 7438, p508 

    Mention BMJ Learning and its online learning resources. Purpose of the current module, "Understanding statistics--'Is there a significant difference?'"; The module's examination of using nebulisers in children with acute asthma; Definition of the confidence interval in clinical trials.

  • intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Mohammed, S.; Goodacre, S. // Emergency Medicine Journal;Dec2007, Vol. 24 Issue 12, p823 

    The article discusses research done on the impact of intravenous and nebulised magnesium sulphate on adults and children with acute asthma. There are approximately 5.2 million people with asthma in Great Britain, in which approximately 60,000 people are admitted in hospitals on an annual basis....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics